Dry Age-Related Macular Degeneration Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Competitive Strategies

 

Dry Age-Related Macular Degeneration Market

Dry Age-Related Macular Degeneration Market

This degenerative eye disease is caused by the thinning of the macula and interferes with a clear vision in the elderly. The macula is part of the retina that facilitates clear vision; when this part of the eye deteriorates, it causes blurred or distorted vision. But this does not mean that the individual will lose his or her sight, only the central vision is affected by this degenerative disease, and the peripheral vision remains intact. Vision loss is slow and can be corrected using innovative ocular treatments. It has been estimated that the Dry Age-Related Macular Degeneration Market has seen a jump due to increased research in drugs, rising amount of COVID-19 cases among the old and age-restricted chronic diseases.

 

The dry age-related macular degeneration AMD market is expected to cross USD 15,351.07 million by 2027 at a CAGR of 8.20% during the forecast period

 

List of Key Companies Covered in this report:

Santen Pharmaceuticals Inc. (Japan), Allergan plc (Ireland), Bausch Health (Canada), Alimera Science Inc. (US), Phio Pharmaceuticals Corp (US), Ocumension Therapeutics Co. Ltd (China), Belite Bio Inc. (US), Kubota Vision Inc. (US), Iveric Bio (US), Eyestem Research Pvt Ltd (India), Yuyang DNU Co., Ltd (South Korea), Stealth Biotherapeutics Inc. (US)

 

Dry Age-Related Macular Degeneration Market Share

It has been reported by the American Academy of Ophthalmology that about 11 million people over the age of fifty experience blindness as a result of AMD. Hence making it a supple market for AMD related treatments. Obesity-related macular degeneration is also on the rise in North America, along with high blood pressure from an erratic lifestyle.

Advances in research and development in Europe and Asia-Pacific have enabled more patients to see more clearly. The African continent, particularly the Sahara subcontinent, has experienced a significant increase in dry age-related macular degeneration due to lack of vitamin A and poor dietary standards. Thus making this region the key player for pharmaceutical companies to invest in.

The key companies that are invested into creating feasible solutions for AMD are Pfizer, Bayer AG, Regenron Pharmaceutical Inc., GlaxoSmithKline plc, and Novartis AG.

 

Dry Age-Related Macular Degeneration Market Growth

The AMD market is led by dry and wet drug solutions that treat this degenerative disease. Wet age-related AMD will soon see a jump of 95% in the year 2022. After the impact of COVID-19, it has been observed that wet macular degeneration has affected most of the ageing population. In this type, there is an atypical growth of blood vessels beneath the retina, causing it to bleed create vision obstruction. Developed countries have introduced intraocular anti-VEGF injections for patients suffering from wet AMD, thus increasing treatment capacity globally.

In recent years, Stargardt disease, a genetically inherited retinal disorder that has become dominant among the younger population, has given impetus for research towards macular degeneration drugs.

Lucentis, Avastin, Eylea and Visudyne are some of the prominent drugs available in the market to treat dry age-related macular degeneration. The Lucentis market has grown rapidly in developed countries since the government introduced healthcare benefits for the elderly through affordable treatments.

 

Dry Age-Related Macular Degeneration Market Value

It has been noted that off-label drugs are getting more popular due to their affordability than on-label drugs to treat AMD. An off-label drug like Avastin is sold rapidly in the market for patients who can get treated within their income budget.

On a case-by-case basis, the market is segmented into intravenous and intravitreous. It is said that the intravitreal segment dominates the market because it is most effective because of the targeted distribution of drugs. Furthermore, the majority of anti-VEGF injections are given intravitreally or intraocular.

 

Industry News

·         Recent data released by the World Bank statistics indicate that the older generation living above 65% is rising. They represent approximately 8.873% of the population, indicating that patients with AMD will increase due to chronic diseases and diseases.

Related Report-

https://topkif.nvinio.com/read-blog/9703_medical-device-cleaning-market-share-size-2021-market-growth-demand-trends-and-f.html

https://www.sdssocial.world/post/113619_central-nervous-system-biomarkers-market-growth-competitive-strategies-regional.html

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Comments

Post a Comment

Popular posts from this blog

Ayurvedic Products Market Outlook, Trend, Growth and Share Estimation Analysis and Forecast 2020-2030

Image
  Global Ayurvedic Products Market Overview Ayurvedic Products are generally used in personal care and healthcare products. Ayurvedic products originated from India, and thus, the concentration of ayurvedic product suppliers is the highest in the country. According to the latest research reports Due to growing inclination for natural treatment, the Ayurvedic Products Market , size is projected to reach USD 28830.5 Million by 2030 at 12.3% CAGR. Many factors are influencing a significant rise in the growth rate between during forecast periods. Increasing adoption of traditional methods for medicinal purposes is observed to cause a significant boost in the global Ayurvedic Products Market With a rise in the working woman population, rising disposable income, and a growing inclination towards chemical free and herbal cosmetics are some of the primary factors contributing to the ascension of the global ayurvedic market. Apart from personal care, ayurvedic healthcare products are...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more

Breast Cancer Market 2022-2027 Worldwide Demand and Growth Analysis Report 2022-2027

Image
  Breast Cancer is the second-most common type of cancer in women and one of the paramount concerns, globally. According to WHO, every year, around 200,000 new cases get registered, and the digits are continuously increasing. Many statistics show that breast cancer is more prevalent in developed countries such as the UK, the US, and Australia as their women are more prone to acquire the disease. This doesn’t mean that women from developing countries like India and China are out of breast cancer’s radar. On the contrary, they are more vulnerable than women from developed regions. Unavailability of proper treatment due to the lack of funds and awareness towards the government’s programs is killing them more than breast cancer can. Advancements in medical science and biotechnology have improved the outlook of diagnosis. However, the recovery is still challenging as survivors adjust to the scars that remain mentally and physically. Surprisingly, the Breast Cancer Market is still a...
Read more